Pulmonary Medicine Featured News April 19, 2019 Bronchoscopic lung volume reduction therapy approved for severe emphysema Bronchoscopic lung volume reduction has emerged as a potential alternative to lung volume reduction surgery and a less invasive method by which to achieve lung volume reduction in patients with emphysema and hyperinflation. Jan. 08, 2019 Multidisciplinary care of idiopathic subglottic stenosis A combined approach of inhaled glucocorticoids, trimethoprim-sulfamethoxazole, and proton-pump inhibitors plus lifestyle modifications for the treatment of idiopathic subglottic stenosis (ISS) suggests that ISS recurs less frequently for patients treated with this strategy than for patients treated with endoscopic therapy. Jan. 11, 2019 Update on the management of ANCA-associated vasculitis Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis comprises three syndromes, all with frequent respiratory manifestations. Studies indicate that ANCA specificity is more important for prognosis, relapse risk, response to therapy and outcomes than the specific diagnosis. Jan. 08, 2019 Update in pleural disease This update addresses some of the latest understanding and approaches to management of malignant pleural disease, including use of the RAPID multistep scoring system to better predict prognosis in those patients who present with pleural space infections. Latest Videos See All Center volume and hereditary hemorrhagic telangiectasia Vivek N. Iyer, M.D., with Pulmonary and Critical Care Medicine at Mayo Clinic in Rochester, Minnesota, discusses a study of patients with the rare disease hereditary hemorrhagic telangiectasia. A new future for cystic fibrosis Cystic fibrosis is one of the most common genetically transmitted diseases, causing repeated infections that lead to lung failure. Gene is linked to lung cancer development in never smokers A five-center collaborative study that scanned the genomes of thousands of "never smokers" diagnosed with lung cancer as well as healthy never smokers has found a gene they say could be responsible for a significant number of those cancers. Clinical Trials See All Timing and Intensity of the Exposures and Attributable Burden of Acute Lung InjuryRochester, Minn.A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerScottsdale/Phoenix, Ariz.Mindful Breathing Awareness Through Pursed-Lip Breathing TrainingRochester, Minn. Publications PRINT EDITION See the latest edition plus past issues E-NEWSLETTER EDITION See the latest edition plus past issues More News 1 Cone-beam CT for enhanced bronchoscopic access to pulmonary nodules 2 Anti-interleukin-5 therapy for severe asthma: A new therapeutic option 3 New technology overcomes false-positives in CT for lung cancer 4 New definitions and diagnoses in interstitial pneumonia 5 Lung transplantation: Challenges and opportunities Medical Professionals Pulmonary Medicine